MCIM
IMDZ

Meadow Creek Investment Management’s Immune Design Corp. IMDZ Stock Holding History

Meadow Creek Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,820
Closed -$40K – 1358
2018
Q2 		$40K Buy
+8,820
New +$35.1K ﹤0.01% 1271

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Meadow Creek Investment Management's IMDZ Position: Q3 2018 in Review

Meadow Creek Investment Management sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 8,820 shares — an estimated $40K sold.

Meadow Creek Investment Management first reported a position in IMDZ in Q2 2018 and held it in 1 quarter. The position peaked at $40K in Q2 2018. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • Meadow Creek Investment Management reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
  • Meadow Creek Investment Management sold 8,820 Immune Design Corp. shares in Q3 2018, an estimated $40K.
  • Meadow Creek Investment Management first reported a position in Immune Design Corp. in Q2 2018 and held it in 1 quarter.
  • Meadow Creek Investment Management's Immune Design Corp. position peaked at $40K in Q2 2018.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Meadow Creek Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.